Header cover image

Canadian (TSX) Pharma Industry Analysis

UpdatedDec 04, 2022
DataAggregated Company Financials
Companies131
  • 7D10.9%
  • 3M4.4%
  • 1Y-43.9%
  • YTD-40.6%

In the last week, the Pharma industry is up 11%, with Green Thumb Industries up 18%. In the same time, High Tide was down 7.2%. However, the industry is down 44% over the past year. As for the next few years, earnings are expected to grow by 63% per annum.

Industry Valuation and Performance

Has the Canadian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 04 Dec 2022CA$33.4bCA$13.6b-CA$10,188,493,690.0016.8x-3.3x2.5x
Tue, 01 Nov 2022CA$29.1bCA$13.4b-CA$9,381,995,629.009.4x-3.1x2.2x
Thu, 29 Sep 2022CA$25.4bCA$13.4b-CA$9,394,947,521.0011.4x-2.7x1.9x
Sat, 27 Aug 2022CA$32.2bCA$13.0b-CA$8,975,043,197.0012.8x-3.6x2.5x
Mon, 25 Jul 2022CA$29.4bCA$12.2b-CA$5,866,752,238.0011.6x-5x2.4x
Wed, 22 Jun 2022CA$27.8bCA$12.2b-CA$5,797,759,306.008.4x-4.8x2.3x
Fri, 20 May 2022CA$31.4bCA$12.0b-CA$5,656,362,054.009.6x-5.5x2.6x
Sun, 17 Apr 2022CA$40.9bCA$11.6b-CA$4,720,834,575.0012.3x-8.7x3.5x
Tue, 15 Mar 2022CA$38.0bCA$10.9b-CA$4,387,716,598.0011.2x-8.7x3.5x
Thu, 10 Feb 2022CA$53.0bCA$10.9b-CA$4,909,046,144.0014.1x-10.8x4.9x
Sat, 08 Jan 2022CA$52.4bCA$10.8b-CA$4,955,792,302.0013.2x-10.6x4.8x
Mon, 06 Dec 2021CA$55.4bCA$10.9b-CA$4,789,068,487.0014.8x-11.6x5.1x
Wed, 03 Nov 2021CA$58.8bCA$10.2b-CA$4,804,236,780.0015.8x-12.2x5.8x
Fri, 01 Oct 2021CA$67.0bCA$10.3b-CA$4,928,350,098.0019.9x-13.6x6.5x
Sun, 29 Aug 2021CA$69.4bCA$10.2b-CA$6,616,236,433.2722x-10.5x6.8x
Mon, 05 Jul 2021CA$83.0bCA$10.2b-CA$6,613,771,569.2724.2x-12.5x8.1x
Thu, 08 Apr 2021CA$88.7bCA$8.8b-CA$7,557,962,787.4023.8x-11.7x10x
Sun, 10 Jan 2021CA$57.0bCA$7.0b-CA$8,796,767,091.1925.1x-6.5x8.1x
Sat, 03 Oct 2020CA$35.8bCA$6.4b-CA$10,187,973,751.0324.5x-3.5x5.6x
Tue, 07 Jul 2020CA$33.7bCA$5.5b-CA$8,871,002,112.2220.7x-3.8x6.1x
Fri, 10 Apr 2020CA$27.2bCA$5.2b-CA$6,469,124,222.039.8x-4.2x5.2x
Thu, 02 Jan 2020CA$39.3bCA$4.3b-CA$4,615,997,528.2815.8x-8.5x9.2x
Price to Earnings Ratio

-8.5x


Total Market Cap: CA$39.3bTotal Earnings: -CA$4,615,997,528.28Total Revenue: CA$4.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Pharma Industry Price to Earnings3Y Average -7.6x20212022
Current Industry PE
  • Investors are pessimistic on the Canadian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 6.2x is higher than the industry's current PS ratio of 2.5x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 47% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market0.40%
Healthcare8.06%
Pharma10.89%
Pharma10.89%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GTII Green Thumb IndustriesCA$20.8918.4%
+CA$766.3m
-20.8%PE42.6x
CURA Curaleaf HoldingsCA$9.808.4%
+CA$545.7m
-17.6%PS4x
WEED Canopy GrowthCA$5.7619.8%
+CA$461.6m
-55.2%PS5.8x
TRUL Trulieve CannabisCA$19.6312.8%
+CA$414.5m
-42.3%PS2.2x
CL Cresco LabsCA$5.1017.2%
+CA$226.2m
-50.9%PS1.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CL

CA$5.10

Cresco Labs

7D

17.2%

1Y

-50.9%

TER

CA$2.89

TerrAscend

7D

17.0%

1Y

-63.9%

WEED

CA$5.76

Canopy Growth

7D

19.8%

1Y

-55.2%

GTII

CA$20.89

Green Thumb Industries

7D

18.4%

1Y

-20.8%

RVV

CA$0.14

Revive Therapeutics

7D

-20.0%

1Y

-71.7%

TILT

CA$0.10

TILT Holdings

7D

-16.0%

1Y

-72.7%

GABY

CA$0.005

GABY

7D

-66.7%

1Y

-83.3%

OGI

CA$1.60

Organigram Holdings

7D

22.1%

1Y

-31.6%

TGOD

CA$0.64

Green Organic Dutchman Holdings

7D

-7.2%

1Y

-44.3%

CRON

CA$4.67

Cronos Group

7D

11.7%

1Y

-12.5%

TRUL

CA$19.63

Trulieve Cannabis

7D

12.8%

1Y

-42.3%

IMCC

CA$2.46

IM Cannabis

7D

-20.6%

1Y

-94.3%

CURA

CA$9.80

Curaleaf Holdings

7D

8.4%

1Y

-17.6%

MMEN

CA$0.04

MedMen Enterprises

7D

-11.1%

1Y

-84.6%